187 related articles for article (PubMed ID: 24549090)
1. Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line.
Rahman HS; Rasedee A; Abdul AB; Zeenathul NA; Othman HH; Yeap SK; How CW; Hafiza WA
Int J Nanomedicine; 2014; 9():527-38. PubMed ID: 24549090
[TBL] [Abstract][Full Text] [Related]
2. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model.
Rahman HS; Rasedee A; How CW; Zeenathul NA; Chartrand MS; Yeap SK; Abdul AB; Tan SW; Othman HH; Ajdari Z; Namvar F; Arulselvan P; Fakurazi S; Mehrbod P; Daneshvar N; Begum H
Int J Nanomedicine; 2015; 10():1649-66. PubMed ID: 25767386
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect.
Rahman HS; Rasedee A; How CW; Abdul AB; Zeenathul NA; Othman HH; Saeed MI; Yeap SK
Int J Nanomedicine; 2013; 8():2769-81. PubMed ID: 23946649
[TBL] [Abstract][Full Text] [Related]
4. Zerumbone induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in Jurkat cell line.
Rahman HS; Rasedee A; Chartrand MS; Othman HH; Yeap SK; Namvar F
Nat Prod Commun; 2014 Sep; 9(9):1237-42. PubMed ID: 25918781
[TBL] [Abstract][Full Text] [Related]
5. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells.
Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL
Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940
[TBL] [Abstract][Full Text] [Related]
6. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway.
Xian M; Ito K; Nakazato T; Shimizu T; Chen CK; Yamato K; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
Cancer Sci; 2007 Jan; 98(1):118-26. PubMed ID: 17129359
[TBL] [Abstract][Full Text] [Related]
7. Apoptogenic activity of 2α,3α-dihydroxyurs-12-ene-28-oic acid from Prunella vulgaris var. lilacina is mediated via mitochondria-dependent activation of caspase cascade regulated by Bcl-2 in human acute leukemia Jurkat T cells.
Woo HJ; Jun do Y; Lee JY; Woo MH; Yang CH; Kim YH
J Ethnopharmacol; 2011 Jun; 135(3):626-35. PubMed ID: 21473903
[TBL] [Abstract][Full Text] [Related]
8. Kaempferol Activates G₂-Checkpoint of the Cell Cycle Resulting in G₂-Arrest and Mitochondria-Dependent Apoptosis in Human Acute Leukemia Jurkat T Cells.
Kim KY; Jang WY; Lee JY; Jun do Y; Ko JY; Yun YH; Kim YH
J Microbiol Biotechnol; 2016 Feb; 26(2):287-94. PubMed ID: 26699757
[TBL] [Abstract][Full Text] [Related]
9. Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB/c mice model.
Rahman HS; Rasedee A; Othman HH; Chartrand MS; Namvar F; Yeap SK; Abdul Samad N; Andas RJ; Muhammad Nadzri N; Anasamy T; Ng KB; How CW
Biomed Res Int; 2014; 2014():563930. PubMed ID: 25276798
[TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway.
Wang F; Ye X; Zhai D; Dai W; Wu Y; Chen J; Chen W
Acta Pharm; 2020 Jun; 70(2):227-237. PubMed ID: 31955141
[TBL] [Abstract][Full Text] [Related]
12. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells.
Abdelwahab SI; Abdul AB; Mohan S; Taha MM; Syam S; Ibrahim MY; Mariod AA
Leuk Res; 2011 Feb; 35(2):268-71. PubMed ID: 20708800
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol: Isolation, and Its Nanostructured Lipid Carriers, Inhibits Cell Proliferation, Induces Cell Apoptosis in Certain Human Cell Lines Carcinoma and Exerts Protective Effect Against Paraquat-Induced Hepatotoxicity.
Elgizawy HA; Ali AA; Hussein MA
J Med Food; 2021 Jan; 24(1):89-100. PubMed ID: 32580673
[TBL] [Abstract][Full Text] [Related]
14. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.
Nordin N; Yeap SK; Rahman HS; Zamberi NR; Abu N; Mohamad NE; How CW; Masarudin MJ; Abdullah R; Alitheen NB
Sci Rep; 2019 Feb; 9(1):1614. PubMed ID: 30733560
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.
Yuan L; Liu C; Chen Y; Zhang Z; Zhou L; Qu D
Int J Nanomedicine; 2013; 8():4339-50. PubMed ID: 24235831
[TBL] [Abstract][Full Text] [Related]
16. Regression of cervical intraepithelial neoplasia by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement of mitochondria-regulated apoptosis.
Abdelwahab SI; Abdul AB; Devi N; Taha MM; Al-zubairi AS; Mohan S; Mariod AA
Exp Toxicol Pathol; 2010 Sep; 62(5):461-9. PubMed ID: 19581075
[TBL] [Abstract][Full Text] [Related]
17. Zerumbone, a Sesquiterpene, Controls Proliferation and Induces Cell Cycle Arrest in Human Laryngeal Carcinoma Cell Line Hep-2.
Jegannathan SD; Arul S; Dayalan H
Nutr Cancer; 2016 Jul; 68(5):865-72. PubMed ID: 27045964
[TBL] [Abstract][Full Text] [Related]
18. Hydrostatic pressure induces apoptosis in the human leukaemic T-cell line Jurkat via the mitochondrial pathway.
Klett MV; Boneberg EM; Trenz K; Knippers R; Illges H
Scand J Immunol; 2004 Oct; 60(4):403-11. PubMed ID: 15379865
[TBL] [Abstract][Full Text] [Related]
19. Zerumbone induces mitochondria-mediated apoptosis via increased calcium, generation of reactive oxygen species and upregulation of soluble histone H2AX in K562 chronic myelogenous leukemia cells.
Rajan I; Jayasree PR; Kumar PR
Tumour Biol; 2015 Nov; 36(11):8479-89. PubMed ID: 26026585
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
